Jpmorgan Chase & CO Cellebrite Di Ltd. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 567,327 shares of CLBT stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

567,327

Previous 331,665 71.05%

Holding current value

$11 Million

Previous $7.31 Million 50.88%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$16.78 - $26.0 $3.95 Million - $6.13 Million	235,662 Added 71.05%	567,327 $11 Million
Q4 2024 Feb 12, 2025	SELL	$16.52 - $22.52 $1.59 Million - $2.16 Million	-95,990 Reduced 22.45%	331,665 $7.31 Million
Q3 2024 Dec 26, 2024	BUY	$11.61 - $17.52 $871,818 - $1.32 Million	75,092 Added 21.3%	427,655 $7.2 Million
Q3 2024 Nov 08, 2024	BUY	$11.61 - $17.52 $871,818 - $1.32 Million	75,092 Added 21.3%	427,655 $7.2 Million
Q2 2024 Dec 26, 2024	SELL	$10.38 - $12.5 $779,454 - $938,650	-75,092 Reduced 17.56%	352,563 $4.21 Million
Q2 2024 Aug 12, 2024	BUY	$10.38 - $12.5 $1.25 Million - $1.51 Million	120,519 Added 51.94%	352,563 $4.21 Million
Q1 2024 Dec 26, 2024	SELL	$8.04 - $12.29 $1.57 Million - $2.4 Million	-195,611 Reduced 45.74%	232,044 $2.57 Million
Q1 2024 May 10, 2024	BUY	$8.04 - $12.29 $292,237 - $446,716	36,348 Added 18.57%	232,044 $2.57 Million
Q4 2023 Dec 26, 2024	SELL	$6.45 - $8.76 $1.5 Million - $2.03 Million	-231,959 Reduced 54.24%	195,696 $1.69 Million
Q4 2023 Feb 12, 2024	BUY	$6.45 - $8.76 $477,022 - $647,863	73,957 Added 60.75%	195,696 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$6.86 - $8.18 $454,104 - $541,483	66,196 Added 119.18%	121,739 $931,000
Q2 2023 Aug 11, 2023	SELL	$5.3 - $7.2 $150,891 - $204,984	-28,470 Reduced 33.89%	55,543 $399,000
Q1 2023 May 11, 2023	BUY	$4.36 - $6.15 $80,376 - $113,375	18,435 Added 28.11%	84,013 $511,000
Q4 2022 Feb 13, 2023	BUY	$3.99 - $4.95 $36,556 - $45,351	9,162 Added 16.24%	65,578 $286,000
Q3 2022 Nov 14, 2022	SELL	$0.75 - $5.95 $1,857 - $14,732	-2,476 Reduced 4.2%	56,416 $221,000
Q2 2022 Aug 11, 2022	BUY	$4.46 - $7.19 $41,892 - $67,535	9,393 Added 18.98%	58,892 $301,000
Q1 2022 May 11, 2022	BUY	$5.34 - $8.12 $162,389 - $246,929	30,410 Added 159.31%	49,499 $317,000
Q4 2021 Feb 10, 2022	BUY	$7.8 - $11.24 $44,179 - $63,663	5,664 Added 42.19%	19,089 $153,000
Q3 2021 Nov 12, 2021	BUY	$9.26 - $12.15 $124,315 - $163,113	13,425 New	13,425 $124,000

Others Institutions Holding CLBT

# of Institutions

218

Shares Held

99.4M

Call Options Held

122K

Put Options Held

80.8K

View Full List

About Cellebrite DI Ltd.

Ticker CLBT
Exchange NASDAQ
Sector Technology
Industry Software—Infrastructure
Shares Outstandng 189,648,992
Market Cap $3.69B
Description
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...

More about CLBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Cellebrite Di Ltd. Transaction History